-
Zotarolimus, or ABT-578, was
originally used on Abbott's
coronary stent platforms to
reduce early inflammation and restenosis; however,
Zotarolimus failed...
-
Everolimus is an
analog of
sirolimus and also is an mTOR inhibitor.
Zotarolimus is a semi-synthetic
derivative of
sirolimus used in drug-eluting stents...
- sarcoma.
Umirolimus is an
immunosuppressant used in drug-eluting stents.
Zotarolimus is an
immunosuppressant used in
coronary drug-eluting stents. The second...
- drug-eluting
stents use
sirolimus (also
known as rapamycin),
everolimus and
zotarolimus.
Biolimus A9-eluting stents,
which utilize biodegradable polymers, are...
- anti-proliferative drug
Zotarolimus to the
arterial vessel wall are
components of
these medical devices. For
targeted local delivery of
Zotarolimus to the artery...
- (INN)
Zorvolex Zoryve Zostavax Zostrix zosuquidar (USAN, INN)
Zosyn zotarolimus (USAN)
zotepine (INN)
Zovia 1/35
Zovia 1/35E-21
Zovia 1/35E-28 Zovia...
- IL-1
receptor antagonists Anakinra mTOR
Everolimus Ridaforolimus Sirolimus Temsirolimus Umirolimus Zotarolimus...
-
terlipressin 14636-12-5 C52H76O24
plicamycin 18378-89-7 C52H79N5O12
zotarolimus 221877-54-9 C52H81N7O16
echinocandin B 54651-05-7 C52H88N10O15 caspofungin...
- DES emit are
antiproliferative agents such as sirolimus, everolimus,
zotarolimus, pa****axel and biolimus.
These drugs help
prevent the
arterial narrowing...
-
Everolimus Ridaforolimus Sirolimus (Rapamycin)
Temsirolimus Umirolimus Zotarolimus; ATP-competitive / indirect:
Berberine Cur****in
Dactolisib EF-24 Epigallocatechin...
